Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Jan 6;53(1):13-35. doi: 10.3760/cma.j.issn.0253-9624.2019.01.004.
Cardiovascular disease (CVD) is the leading cause of death and burden of diseases in China. Prevention and control of CVD has been challenging. Risk assessment and management for CVD risk factors are essential for primary prevention of CVD. According to recent observational and interventional evidences worldwide and studies in Chinese population, the guideline introduced how to conduct cardiovascular risk assessment in China, including the procedure for 10-year and lifetime risk assessment, the risk stratification, and the application of web-based and mobile risk assessment tools. Furthermore, in order to facilitate the primary prevention of CVD, the guideline targeted therapeutic lifestyle changes, and highlighted principles for management of blood pressure, lipids, and glucose, etc. The implementation of the guideline will facilitate the risk assessment of CVD and risk factor management, and promote both individualized and community-based prevention of CVD in China.
心血管疾病（CVD）是中国主要的死亡原因和疾病负担。心血管疾病的预防和控制一直具有挑战性。心血管疾病危险因素的风险评估和管理对于心血管疾病的一级预防至关重要。根据全球最近的观察性和干预性证据以及中国人群的研究，本指南介绍了在中国如何进行心血管风险评估，包括10年和终生风险评估的程序、风险分层以及基于网络和移动风险评估工具的应用。此外，为了促进心血管疾病的一级预防，本指南针对治疗性生活方式改变，并强调了血压、血脂和血糖等管理原则。本指南的实施将有助于心血管疾病的风险评估和危险因素管理，并促进中国心血管疾病的个体化和基于社区的预防。
